122 related articles for article (PubMed ID: 1812009)
1. Reduced peptide bond pseudopeptide analogues of neurotensin: binding and biological activities, and in vitro metabolic stability.
Lugrin D; Vecchini F; Doulut S; Rodriguez M; Martinez J; Kitabgi P
Eur J Pharmacol; 1991 Nov; 205(2):191-8. PubMed ID: 1812009
[TBL] [Abstract][Full Text] [Related]
2. Reduced peptide bond pseudopeptide analogues of neurotensin.
Doulut S; Rodriguez M; Lugrin D; Vecchini F; Kitabgi P; Aumelas A; Martinez J
Pept Res; 1992; 5(1):30-8. PubMed ID: 1623301
[TBL] [Abstract][Full Text] [Related]
3. [TRP11]-neurotensin and xenopsin discriminate between rat and guinea-pig neurotensin receptors.
Checler F; Labbé C; Granier C; van Rietschoten J; Kitabgi P; Vincent JP
Life Sci; 1982 Sep; 31(11):1145-50. PubMed ID: 6292604
[TBL] [Abstract][Full Text] [Related]
4. JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse.
Dubuc I; Costentin J; Doulut S; Rodriguez M; Martinez J; Kitabgi P
Eur J Pharmacol; 1992 Aug; 219(2):327-9. PubMed ID: 1425958
[TBL] [Abstract][Full Text] [Related]
5. [Radioactive analogs of neurotensin. II. Preparation of tritiated neurotensin from a synthetic multi-unsaturated derivative].
Labbé-Jullié C; Blanot D; Morgat JL; Kitabgi P; Checler F; Vincent JP; Granier C; Van Rietschoten J
Biochimie; 1983 Oct; 65(10):553-62. PubMed ID: 6317062
[TBL] [Abstract][Full Text] [Related]
6. Ketomethylene and (cyanomethylene)amino pseudopeptide analogues of the C-terminal hexapeptide of neurotensin.
González-Muñiz R; García-López MT; Gómez-Monterrey I; Herranz R; Jimeno ML; Suárez-Gea ML; Johansen NL; Madsen K; Thøgersen H; Suzdak P
J Med Chem; 1995 Mar; 38(6):1015-21. PubMed ID: 7699693
[TBL] [Abstract][Full Text] [Related]
7. Interaction of xenin with the neurotensin receptor of guinea pig enteral smooth muscles.
Feurle GE; Metzger JW; Grudinski A; Hamscher G
Peptides; 2002 Mar; 23(3):523-9. PubMed ID: 11836002
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of psi (CH2NH) pseudopeptide analogues of the C-terminal hexapeptide of neurotensin.
Couder J; Tourwé D; Van Binst G; Schuurkens J; Leysen JE
Int J Pept Protein Res; 1993 Feb; 41(2):181-4. PubMed ID: 8458692
[TBL] [Abstract][Full Text] [Related]
9. New reduced peptide bond substance P agonists and antagonists: effects on smooth muscle contraction.
Zacharia S; Rossowski WJ; Jiang NY; Hrbas P; Ertan A; Coy DH
Eur J Pharmacol; 1991 Oct; 203(3):353-7. PubMed ID: 1723044
[TBL] [Abstract][Full Text] [Related]
10. Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1.
Meyer JP; Davis P; Lee KB; Porreca F; Yamamura HI; Hruby VJ
J Med Chem; 1995 Sep; 38(18):3462-8. PubMed ID: 7658433
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
12. Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors.
Sadoul JL; Mazella J; Amar S; Kitabgi P; Vincent JP
Biochem Biophys Res Commun; 1984 May; 120(3):812-9. PubMed ID: 6329185
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities.
Granier C; van Rietschoten J; Kitabgi P; Poustis C; Freychet P
Eur J Biochem; 1982 May; 124(1):117-24. PubMed ID: 7084220
[No Abstract] [Full Text] [Related]
14. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
[TBL] [Abstract][Full Text] [Related]
15. Interaction of xenin with the neurotensin receptor of guinea pig enteral smooth muscles.
Feurle GE; Metzger JW; Grudinki A; Hamscher G
Peptides; 2002 Aug; 23(8):1519-25. PubMed ID: 12182956
[TBL] [Abstract][Full Text] [Related]
16. Effects of guinea pig neurotensin ([Ser7]neurotensin) on gastrointestinal smooth muscle.
Katsoulis S; Conlon JM
Eur J Pharmacol; 1987 Aug; 140(3):353-6. PubMed ID: 3653250
[TBL] [Abstract][Full Text] [Related]
17. Comparison of some biological properties of neurotensin and its natural analogue LANT-6.
Kitabgi P; Checler F; Vincent JP
Eur J Pharmacol; 1984 Apr; 99(4):357-60. PubMed ID: 6329790
[TBL] [Abstract][Full Text] [Related]
18. Effects of neurotensin on isolated intestinal smooth muscles.
Kitabgi P; Freychet P
Eur J Pharmacol; 1978 Aug; 50(4):349-57. PubMed ID: 699961
[TBL] [Abstract][Full Text] [Related]
19. Compared binding properties of 125I-labeled analogues of neurotensin and neuromedin N in rat and mouse brain.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1994 Jan; 62(1):361-8. PubMed ID: 8263537
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of CCK26-33-related analogues modified in position 31.
Marseigne I; Dor A; Bégué D; Reibaud M; Zundel JL; Blanchard JC; Pélaprat D; Roques BP
J Med Chem; 1988 May; 31(5):966-70. PubMed ID: 2452253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
